Biocytogen Beijing Animal Center is a strategic resource hub of Biocytogen for the translation from gene-editing animal model generation to new drug discovery and development, with 30,000 cages and the 12,000 m2 animal facility. The center offers a wide spectrum of supports for new animal model generation and R&D services, including the establishment and colony expansion for the gene-edited animals, in vivo drug efficacy test and screening, and animal immunization for antibody discovery, etc. It is also the core center to promote Biocytogen's "RenMice® HiTS Platform", which is an open and collaborative project to develop antibody hits for thousands of potential drug targets through targeted genetic disruption of RenMab® mice, together with global partners to achieve the goal of developing new drugs through innovation in technology and ideas.
+86-10-56967680
info@bbctg.com.cn